Format

Send to

Choose Destination
See comment in PubMed Commons below
J Biomed Sci. 2007 Mar;14(2):275-84. Epub 2007 Jan 24.

Genistein and daidzein induce neurotoxicity at high concentrations in primary rat neuronal cultures.

Author information

1
Department of Biomedical Science, Florida Atlantic University, Boca Raton, FL 33431, USA.

Abstract

It is known that estrogen can protect neurons from excitotoxicity. Since isoflavones possess estrogen-like activity, it is of interest to determine whether isoflavones can also protect neurons from glutamate-induced neuronal injury. Morphological observation and lactate dehydrogenase (LDH) release assay were used to estimate the cellular damage. It is surprising that, contrary to estrogen, isoflavones, specifically genistein and daidzein, are toxic to primary neuronal culture at high concentration. Treatment of neurons with 50 microM genistein and daidzein for 24 h increased LDH release by 90% and 67%, respectively, indicating a significant cellular damage. Under the same conditions, estrogen such as 17beta-estradiol did not show any effect on primary culture of brain cells. At 100 microM, both genistein and daidzein increased LDH release by 2.6- and 3-fold, respectively with a 30-min incubation. Furthermore, both genistein and daidzein at 50 microM increased the intracellular calcium level, [Ca(2+)](i), significantly. To determine their mode of action, genistein and daidzein were tested on glutamate and GABA(A)receptor binding. Both genistein and daidzein were found to have little effect on glutamate receptor binding, while the binding of [(3)H]muscimol to GABA(A) receptors was markedly inhibited. However, 17beta-estradiol did not affect GABA(A) receptor binding suggesting that the toxic effect of genistein and daidzein could be due to their inhibition of the GABA(A) receptor resulting in further enhancement of excitation by glutamate and leading to cellular damage.

PMID:
17245525
DOI:
10.1007/s11373-006-9142-2
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center